Q5110 – Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram

Long description

Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram

Short description

Nivestym

Pricing indicator

51 Drugs

Medicare coverage

D Special coverage instructions apply

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

October 1, 2018

Last change

October 1, 2018 – No change

Nearby Q codes

• Q5102 – Injection, infliximab, biosimilar, 10 mg
• Q5103 – Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
• Q5104 – Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
• Q5105 – Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
• Q5106 – Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
• Q5107 – Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
• Q5108 – Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
• Q5109 – Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
• Q5111 – Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
• Q5112 – Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
• Q5113 – Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
• Q5114 – Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg
• Q5115 – Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
• Q5116 – Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
• Q5117 – Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
• Q5118 – Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg